Latest News and Events
Filter by
Selections
November 6, 2023
Arrowhead Pharmaceuticals to Participate in Jefferies London Healthcare Conference
Read MoreNovember 2, 2023
Arrowhead Pharmaceuticals to Present New Phase 2 Clinical Data on Cardiometabolic Pipeline at AHA 2023
Read MoreOctober 31, 2023
GSK enters agreement to obtain exclusive license for JNJ-3989 to expand the development of bepirovirsen
Read MoreOctober 3, 2023
Arrowhead Pharmaceuticals to Participate in Upcoming October 2023 Conferences
Read MoreSeptember 27, 2023
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Read MoreSeptember 1, 2023